# A Pharmacodynamic Study of the Apheresis Product of Multiple Myeloma Patients Undergoing Quad-induction Followed by Motixafortide + G-CSF Mobilization

> **NCT06547112** · PHASE1 · COMPLETED · sponsor: **Washington University School of Medicine** · enrollment: 20 (actual)

## Conditions studied

- Multiple Myeloma

## Interventions

- **DRUG:** Motixafortide
- **DRUG:** G-CSF

## Key facts

- **NCT ID:** NCT06547112
- **Lead sponsor:** Washington University School of Medicine
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-10-31
- **Primary completion:** 2025-07-23
- **Final completion:** 2025-08-19
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2025-08-29

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06547112

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06547112, "A Pharmacodynamic Study of the Apheresis Product of Multiple Myeloma Patients Undergoing Quad-induction Followed by Motixafortide + G-CSF Mobilization". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT06547112. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*